Courtesy of Benzinga.
Neuroderm Ltd (NASDAQ: NDRM) +30% – The company announced favorable Phase IIa Parkinson’s treatment study results.
China Jo-Jo Drugstores Inc (NASDAQ: CJJD) +9% – Shares are higher following a report of potential legalization of online prescription drugs sales in China.
XenoPort, Inc. (NASDAQ: XNPT) +9% – Late Monday, RBC analyst Michael Yee said XenoPort is his “under the radar play for 2015.”
Kandi Technologies Group Inc (NASDAQ: KNDI) +4.3% – The rise in share price is a result of the announcement that China will extend green vehicle subsidies until 2020.
Cnova NV (NASDAQ: CNV) +3% – Shares were initiated with an Overweight rating at JPMorgan and Morgan Stanleyand a Buy rating at Bank of America.
Idera Pharmaceuticals Inc (NASDAQ: IDRA) +1.8% – The company received FDA orphan drug designation for IMO-8400.
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) +1% – Ariad announced a commercialization deal for Iclusig in seven countries.
Microsoft Corporation (NASDAQ: MSFT) +0.11% – Microsoft named “top pick” at Piper Jaffray for 2015.
Civeo Corp (NYSE: CVEO) -35% – After hours Monday, the company announced Q1 guidance below estimates and suspended its quarterly dividend.
Medbox Inc (OTC: MDBX) -16% – The company announced it will amend prior period financial results.
Procter & Gamble Co (NYSE: PG) -1% – Shares were downgraded to Neutral at BTIG.
Posted-In: Bank of America JP Morgan Michael Yee Morgan StanleyPre-Market Outlook Movers
